Quality of time spent without symptoms of disease or toxicity of treatment for transmetatarsal amputation versus digital amputation in diabetic patients with digital gangrene

Abstract

Aim

We aim to compare the outcome of diabetic patients with gangrenous toes who were managed initially either by digital amputation or by transmetatarsal amputation. The null hypothesis is that transmetatarsal amputation had less theatre trips and better healing.

Materials and Methods

A parallel observational comparative study of all diabetic patients who underwent either digital or transmetatarsal amputation in a tertiary referral center from 2002 through 2015. Comorbid conditions, subsequent amputations, hospital stay, and readmission were noted.

Results

A total of 223 patients underwent minor amputation during the study period, of which 147 patients were diabetic and 76 patients were non-diabetic. Seventy-seven patients had digital amputation and 70 transmetatarsal amputation in diabetic patients. Demographics were similar in both groups. The median time to major amputation was (400 ± IQR 1205 days) in the digital amputation group, compared to 690 ± IQR 891 days in the transmetatarsal amputation group (P = 0.974). 29.9% of digital amputations and 15.7% of transmetatarsal amputations in diabetic patients, required minor amputations or revision procedures (P = 0.04). Median length of hospital stay was (20 days, IQR 27) in the digital group and (17 days, IQR17) in the transmetatarsal amputation group (P = 0.17). Need for re-admission was 48.1% in digital patients compared to 50% in transmetatarsal amputation patients (P = 0.81). Quality of time spent without symptoms of disease or toxicity of treatment (Q-TWiST) was (315 days, IQR 45) in digital group and (346 days, IQR 48) in the transmetatarsal amputation patients (P = 0.099).

Conclusion

Despite the lack of statistical significance, transmetatarsal amputation offered better outcome in the diabetic patients, with less re-intervention rate, shorter hospital stays, less theatre trips, and longer time without toxicity (TWiST).

Keywords

Forefoot digital transmetatarsal amputation diabetes outcome

Get full access to this article

View all access options for this article.

References

Armstrong

Lavery

Stern

et al.

Is prophylactic diabetic foot surgery dangerous?

J Foot Ankle Surg 1996; 35: 585–589.

Moss

Klein

and Klein

BE.

The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Diabetes Care 1999; 22: 951–959.

Taylor

York

Cull

et al.

Clinical success using patient-oriented outcome measures after lower extremity bypass and endovascular intervention for ischemic tissue loss. J Vasc Surg 2009; 50: 534–541.

Mills

Sr Conte

Armstrong

et al.

The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014; 59: 220–234.e1-2.

Cull

Manos

Hartley

et al.

An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system.

J Vasc Surg 2014; 60: 1535–1541.

Bogart

Jouin

Behal

et al.

Analysis of survival adjusted for quality of life using the Q-TWiST function: Interface in R.

Comput Methods Programs Biomeds 2016; 125: 79–87.

Boffeli

and Reinking

Plantar rotational flap technique for panmetatarsal head resection and transmetatarsal amputation: a revision approach for second metatarsal head transfer ulcers in patients with previous partial first ray amputation.

J Foot Ankle Surg 2014; 53: 96–100.

Berceli

Brown

Irwin

et al.

Clinical outcomes after closed, staged, and open forefoot amputations.

J Vasc Surg 2006; 44: 347–352. e2.

Boulton

AJM

Hardisty

Betts

et al.

Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy.

Diabetes Care 1983; 6: 26–33.

10.

Pham

Armstrong

Harvey

et al.

Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Diabetes Care 2000; 23: 606–611.

11.

Pataky

Golay

Bounameaux

et al.

Relationship between peripheral vascular disease and high plantar pressures in diabetic neuro-ischaemic patients.

Diabetes Metabol 2003; 29: 489–495.

12.

Pollard

Hamilton

Rush

et al.

Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases.

J Foot Ankle Surg 2006; 45: 91–97.

13.

Borkosky

and Roukis

TS.

Incidence of repeat amputation after partial first ray amputation associated with diabetes mellitus and peripheral neuropathy: an 11-year review.

J Foot Ankle Surg 2013; 52: 335–338.

14.

Lavery

and Quebedeax-Farnham

TL.

Increased foot pressures after great toe amputation in diabetes.

Diabetes Care 1995; 18: 1460–1462.

15.

Murdoch

Armstrong

Dacus

et al.

The natural history of great toe amputations.

J Foot Ankle Surg 1997; 36: 204–208.

16.

Borkosky

and Roukis

. Incidence of re-amputation following partial first ray amputation associated with diabetes mellitus and peripheral sensory neuropathy: a systematic review. Diabet Foot Ankle 2012; 3: 1, 12169. doi: 10.3402/dfa.v3i0.12169.

17.

Dalla Paola

Carone

Morisi

et al.

Conservative surgical treatment of infected ulceration of the first metatarsophalangeal joint with osteomyelitis in diabetic patients.

J Foot Ankle Surg 2015; 54: 536–540.

18.

Nehler

Whitehill

Bowers

et al.

Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status.

J Vasc Surg 1999; 30: 509–517.

19.

Tracy

Lord

Hill

et al.

Management of ischemia of the foot beyond arterial reconstruction. Surg Gynecol Obstet 1982; 155: 377–379.

20.

Durham

McCoy

Sawchuk

et al.

Open transmetatarsal amputation in the treatment of severe foot infections.

Am J Surg 1989; 158: 127–130.

21.

Quigley

Faris

and Xiouruppa

Transmetatarsal amputation for advanced forefoot tissue loss in elderly patients.

Aust N Z J Surgery 1995; 65: 339–341.

22.

Hosch

Quiroga

Bosma

et al.

Outcomes of transmetatarsal amputations in patients with diabetes mellitus.

J Foot Ankle Surg 1997; 36: 430–434.

23.

Mueller

Allen

and Sinacore

DR.

Incidence of skin breakdown and higher amputation after transmetatarsal amputation: implications for rehabilitation.

Arch Phys Medicine Rehabil 1995; 76: 50–54.

24.

Mwipatayi

Naidoo

Jeffery

et al.

Transmetatarsal amputation: three-year experience at Groote Schuur Hospital.

World J Surg 2005; 29: 245–248.

25.

Hingorani

LaMuraglia

Henke

et al.

The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine.

J Vasc Surg 2016; 63: 3s–21s.